News Digest / Ticker: ORIC

Ticker: ORIC

09:13am, Friday, Nov 07, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Shares Climb Post Publication on Promising Cancer Drug

Oric Pharmaceuticals' stock edges higher after unveiling peer-reviewed findings on enozertinib, a brain-penetrant EGFR exon 20 mutation inhibitor showing remarkable preclinical efficacy in NSCLC treatment.